NasdaqGS - Nasdaq Real Time Price USD
Pacific Biosciences of California, Inc. (PACB)
Tune into earnings calls Now streaming directly on quote pages.
1.1000
-0.1000
(-8.33%)
As of 2:32:53 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 7 | 12 |
| Avg. Estimate | -0.17 | -0.17 | -0.65 | -0.57 |
| Low Estimate | -0.17 | -0.17 | -0.68 | -0.7 |
| High Estimate | -0.15 | -0.15 | -0.59 | -0.42 |
| Year Ago EPS | -0.2 | -0.17 | -0.83 | -0.65 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 13 | 13 |
| Avg. Estimate | 37.08M | 40.16M | 158.78M | 190.59M |
| Low Estimate | 34M | 37.9M | 150.28M | 164.53M |
| High Estimate | 39.7M | 42.4M | 167M | 224.28M |
| Year Ago Sales | 36.01M | 39.97M | 154.01M | 158.78M |
| Sales Growth (year/est) | 2.95% | 0.49% | 3.09% | 20.03% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.22 | -0.21 | -0.17 | -0.19 |
| EPS Actual | -0.2 | -0.17 | -0.2 | -0.15 |
| Difference | 0.02 | 0.04 | -0.03 | 0.04 |
| Surprise % | 10.51% | 20.06% | -15.50% | 20.51% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.17 | -0.17 | -0.65 | -0.57 |
| 7 Days Ago | -0.18 | -0.18 | -0.71 | -0.58 |
| 30 Days Ago | -0.19 | -0.18 | -0.73 | -0.59 |
| 60 Days Ago | -0.19 | -0.18 | -0.73 | -0.59 |
| 90 Days Ago | -0.16 | -0.15 | -0.64 | -0.54 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 1 | 1 |
| Up Last 30 Days | 1 | 2 | 1 | 1 |
| Down Last 7 Days | 1 | 1 | 2 | 2 |
| Down Last 30 Days | 1 | 1 | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PACB | 17.50% | 2.64% | 21.51% | 11.75% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Buy to Buy | 4/10/2025 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 3/25/2025 |
| Reiterates | Piper Sandler: Neutral to Neutral | 2/20/2025 |
| Maintains | Goldman Sachs: Neutral to Neutral | 2/18/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 2/18/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 2/14/2025 |
Related Tickers
BFLY Butterfly Network, Inc.
2.2250
-1.98%
QSI Quantum-Si incorporated
1.2678
-4.68%
LAB Standard BioTools Inc.
1.1050
-0.90%
CERS Cerus Corporation
1.3150
-3.31%
SENS Senseonics Holdings, Inc.
0.6206
-15.77%
MASS 908 Devices Inc.
5.70
-1.55%
NNOX Nano-X Imaging Ltd.
5.26
+1.54%
DXCM DexCom, Inc.
84.94
-0.47%
QDEL QuidelOrtho Corporation
36.23
-0.64%
ZBH Zimmer Biomet Holdings, Inc.
95.74
+0.66%